본문 바로가기
HOME> 저널/프로시딩 > 저널/프로시딩 검색상세

저널/프로시딩 상세정보

권호별목차 / 소장처보기

H : 소장처정보

T : 목차정보

Journal of cardiac failure 12건

  1. [해외논문]   Table of Contents   SCIE


    Journal of cardiac failure v.23 no.12 ,pp. A2 - A3 , 2017 , 1071-9164 ,

    초록

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지
  2. [해외논문]   Masthead   SCIE


    Journal of cardiac failure v.23 no.12 ,pp. A4 - A4 , 2017 , 1071-9164 ,

    초록

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지
  3. [해외논문]   Information for Authors   SCIE


    Journal of cardiac failure v.23 no.12 ,pp. A5 - A6 , 2017 , 1071-9164 ,

    초록

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지
  4. [해외논문]   Editorial Board   SCIE


    Journal of cardiac failure v.23 no.12 ,pp. A1 - A1 , 2017 , 1071-9164 ,

    초록

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지
  5. [해외논문]   How We are Doing: The Journal Enters Its 25th Year   SCIE

    Hauptman, Paul J. (Reprint requests: Paul J. Hauptman, MD, FHFSA, Saint Louis University Hospital, 3635 Vista Avenue, Saint Louis, Missouri 63110. Tel: 314 268 5293)
    Journal of cardiac failure v.23 no.12 ,pp. 833 - 834 , 2017 , 1071-9164 ,

    초록

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지
  6. [해외논문]   Hemodynamic Determinants of the Biologic Variation of N-Terminal Pro–B-Type Natriuretic Peptide in Patients With Stable Systolic Chronic Heart Failure   SCIE

    Tä (Reprint requests: Lutz Frankenstein, Department of Cardiology, Angiology, and Pulmology, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany. Tel: 0049 6221 56 38895) , ger, Tobias (Fax: 0049 6221 56 33575.) , Wiedergruen, Ann-Kathrin , Frö , hlich, Hanna , Cebola, Rita , Corletto, Anna , Horsch, Andrea , Hess, Georg , Slottje, Karen , Zdunek, Dietmar , Katus, Hugo A. , Wians Jr, Frank H. , Frankenstein Jr, Lutz
    Journal of cardiac failure v.23 no.12 ,pp. 835 - 842 , 2017 , 1071-9164 ,

    초록

    Abstract Background Context Biologic variation of N-terminal pro–B-type natriuretic peptide (NT-proBNP) in chronic heart failure (CHF) may affect blood levels and risk stratification. The sources of NT-proBNP variation are unknown. Methods and Results We performed NT-proBNP measurements and clinical and hemodynamic assessments in 50 patients with heart failure with reduced ejection fraction (HFrEF) who met criteria for clinical stability over 2 time intervals. Hemodynamic variables were measured with the use of inert gas rebreathing and impedance cardiography. Heart rhythm was monitored with the use of external electrocardiographic event recorders throughout the study. Determinants of NT-proBNP-levels and both absolute (ΔNT-proBNP abs ) and relative (ΔNT-proBNP % ) changes at 1-week and 2-week intervals were identified with the use of univariable and multivariable linear mixed-effects models and linear regression analyses, respectively. Clinical and hemodynamic variables did not significantly change between study visits. The individual variation of NT-proBNP at 2 weeks was 9.2% (range 3.9%–18.6%). Weight and glomerular filtration rate were independently associated with baseline NT-proBNP concentrations ( P = .01 and P = .005, respectively). There was no relationship between absolute and relative changes of NT-proBNP at 1-week intervals and changes in clinical and hemodynamic variables. Absolute change of NT-proBNP at 2-week intervals was associated with absolute change in left cardiac work index ( P = .008), and relative change in NT-proBNP at 2-week intervals was determined by relative change of thoracic fluid content index ( P = .008) and diastolic blood pressure ( P = .01). The coefficients of determination ( R 2 ) for the multivariable models with Δ 1wk NT-proBNP abs , Δ 2-weeks NT-proBNP abs , Δ 1wk NT-proBNP % , and Δ 2wks NT-proBNP % as dependent variables were 0.21, 0.19, 0.10, and 0.32, respectively. Conclusions In patients with stable HFrEF, changes in clinical and hemodynamic variables only marginally contribute to the variation of NT-proBNP. Highlights Sources of biologic variation of NT-proBNP in CHF patients are largely unknown. Latent hemodynamic changes may confound biologic variation. Their impact was studied in 50 patients with suprastable CHF. Even in those patients, they marginally contribute to the variation of NT-proBNP.

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지
  7. [해외논문]   Pharmacotherapy Use in Older Patients With Heart Failure and Reduced Ejection Fraction After a Skilled Nursing Facility Stay   SCIE

    Li, Lin (Reprint requests: Lin Li, MD, PhD, 368 Plantation Street, AS7-2063, Worcester, MA 01605. Tel: +508 856 8999) , Jesdale, Bill M. (Fax: +508 856 8993.) , Hume, Anne , Gambassi, Giovanni , Goldberg, Robert J. , Lapane, Kate L.
    Journal of cardiac failure v.23 no.12 ,pp. 843 - 851 , 2017 , 1071-9164 ,

    초록

    Abstract Background Little is known about guideline-directed pharmacotherapy use in patients with heart failure and reduced ejection fraction (HFrEF) discharged to skilled nursing facilities (SNFs). This study aimed to describe the use of angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blocker (ARBs) and evidence-based β-blockers (EBBBs) among older patients with HFrEF within 90 days after the SNF admission and to identify factors associated with receipt of these medications. Methods and Results With the use of Minimum Data Set 3.0 cross-linked with Medicare data (2011–2012), we studied 35,792 Americans aged ≥65 years with HFrEF admitted to 10,333 SNFs. The median age was 82 years, 59% were women, 81% had at least moderate physical limitations, and 39% had moderate/severe cognitive impairment. Fifty-six percent received an ACEI/ARB and 53% an EBBB; one-fourth received neither. In a multivariable log-binomial model, advanced age, severe physical limitations, and greater number of comorbid conditions not associated with heart failure were inversely associated with ACEI/ARB and EBBB receipt. Conclusions Use of standard pharmacotherapy among patients with HFrEF after an SNF stay is higher than previously reported. In the absence of evidence demonstrating the effectiveness of ACEIs/ARBs and EBBBs in this population, whether or not improvements in prescribing are warranted remains unknown. Highlights Three-fourths of SNF HFrEF patients used ACEIs/ARBs or evidence-based β-blockers. Advanced age was inversely associated with these treatment practices. Severe physical limitations were inversely associated with these treatment practices. Use of recommended treatments was low in HFrEF patients with multimorbidity.

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지
  8. [해외논문]   Temporal Differences in Outcomes During Long-Term Mechanical Circulatory Support   SCIE

    Maltais, Simon (Reprint requests: Simon Maltais, MD, PhD, Department of Cardiovascular Surgery, Mayo Clinic, 200 First St. SW, Rochester, MN 55905. Tel: +507 255 7067) , Anwer, Lucman A. (Fax: 507-255-7378.) , Haglund, Nicholas A. , Cowger, Jennifer , Shah, Palak , Aaronson, Keith D. , Pagani, Francis D. , Dunlay, Shannon M. , Singh, Ramesh , Salerno, Christopher T. , Stulak, John M.
    Journal of cardiac failure v.23 no.12 ,pp. 852 - 858 , 2017 , 1071-9164 ,

    초록

    Abstract Background Device indications have changed for placement of continuous-flow left ventricular assist devices (CF-LVADs). We performed a multicenter analysis evaluating temporal variations in outcomes after CF-LVAD implantation. Methods & Results We retrospectively defined 3 time intervals to reflect changes in CF-LVAD technology (period 1, 2004–2009; period 2, 2010–2012; and period 3, 2012–2014). A total of 1,064 patients (Heartmate II [HMII] = 835; Heartware [HVAD] = 229) underwent CF-LVAD implantation from May 2004 to October 2014. Device utilization was different between periods: period 1: HMII = 134 (100%); period 2: HMII = 480 (88%) and HW = 63 (12%); and period 3: HMII = 221 (57%) and HW = 166 (43%); P P = .96). Adjusted multivariable analysis revealed age (per 10-year increase) and Interagency Registry for Mechanically Assisted Circulatory Support category (1 vs all others) as the only independent predictors of mortality: P P = .008, respectively. Furthermore, it also showed the later periods to be at an increased risk of adverse events: 1) pump thrombosis (periods 2 and 3); and 2) gastrointestinal bleeding (period 3). Conclusions Despite significant differences in device types, indications, and patient characteristics, post-implantation survivals were similar across time intervals. The most recent cohort seems to be at an increased risk of gastrointestinal bleeding and pump thrombosis. Highlights Placement indications for continuous-flow LVADs have changed. Three distinct time periods corresponding to landmark changes in practice can be identified. Despite differences, survivals are similar among time periods. The most recent period is at an increased risk of gastrointestinal bleeding and pump thrombosis. Temporal observations should help to develop targeted guidelines to improve outcomes.

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지
  9. [해외논문]   Outcomes of Restrictive and Hypertrophic Cardiomyopathies After LVAD: An INTERMACS Analysis   SCIE

    Patel, Snehal R. (Reprint requests: Snehal R. Patel, MD, 3400 Bainbridge Avenue, 7th floor, Bronx, New York 10467. Tel: (718) 920 6238) , Saeed, Omar (Fax: + 17186521883. ) , Naftel, David (Department of Cardiothoracic Surgery, Montefiore Medical Center, Bronx, NY) , Myers, Susan , Kirklin, James , Jorde, Ulrich P. , Goldstein, Daniel J.
    Journal of cardiac failure v.23 no.12 ,pp. 859 - 867 , 2017 , 1071-9164 ,

    초록

    Abstract Background Patients with restrictive (RCM) and hypertrophic (HCM) cardiomyopathies are felt to be a difficult population to treat with left ventricular assist device (LVAD) therapy. Scarce data exist on outcomes of continuous-flow (CF) LVAD support in these challenging patient cohorts. Methods The Interagency Registry for Mechanically Assisted Circulatory Support Registry was queried for all patients with RCM (n = 94) and HCM (n = 104) who underwent CF LVAD implantation between March 2008 and March 2014. Survival, adverse event rates, baseline demographics, echocardiography parameters, and competing outcomes were compared with patients with dilated cardiomyopathy (DCM) (n = 8749). Results Left ventricular size was smaller and baseline EF was higher in RCM and HCM compared with DCM patients. Nonetheless, these parameters were not completely normal in the RCM and HCM groups, suggesting that most of these patients exhibited features of a DCM and represented a mixed phenotype. In these specific patient populations, survival up to 4 years was not different among the 3 groups (log rank 0.25) and competing outcomes at 1 year were similar. In the subgroup of patients with very small ventricles (ie, Conclusion Relatively few patients with HCM and RCM undergo CF LVAD implantation, and most that do display some features of a DCM. Overall survival and adverse event profiles of these patients were similar to traditional DCM patients; however, in those with very small ventricles, survival was inferior. Highlights Scarce data exist on hypertrophic and restrictive cardiomyopathies in patients undergoing left ventricular assist devices (LVAD). Interagency Registry for Mechanically Assisted Circulatory Support is a registry of all approved LVADs and a source to study rare indications. Relatively few patients with these diagnoses have undergone LVAD. Overall survival and adverse events after LVAD implant was similar to patients with a dilated cardiomyopathy. Those with very small ventricles have far inferior survival.

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지
  10. [해외논문]   Contemporary Epidemiology, Management, and Outcomes of Patients Hospitalized for Heart Failure in China: Results From the China Heart Failure (China-HF) Registry   SCIE

    Zhang, Yuhui (Reprint requests: Jian Zhang, MD, PhD, State Key Laboratory of Cardiovascular Disease, Heart Failure Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China. Tel: +86 13,91110,2015, Fax: +86 (10) 8839 6180,) , Zhang, Jian , Butler, Javed , Yang, Xiaomin , Xie, Peiyi , Guo, Dongshuang , Wei, Tiemin , Yu, Jing , Wu, Zhenli , Gao, Yingchun , Han, Xiumin , Zhang, Xuelian , Wen, Susheng , Anker, Stefan D. , Filippatos, Gerasimos , Fonarow, Gregg C. , Gan, Tianyi , Zhang, Rongcheng
    Journal of cardiac failure v.23 no.12 ,pp. 868 - 875 , 2017 , 1071-9164 ,

    초록

    Abstract Background Contemporary data on the epidemiology of heart failure (HF) in China are scarce. The China-HF Registry was designed to investigate clinical characteristics, management, and outcomes of patients hospitalized for HF in China. Methods and Results Data were collected prospectively on 13,687 patients with a primary discharge diagnosis of HF who were enrolled from 132 participating hospitals from January 2012 to September 2015. Data from the China-HF Registry was compared with previously published literature. The mean age was 65 ± 15 years, 59.1% were male, and 36.0% had preserved ejection fraction. Age, body mass index, and systolic blood pressure were lower than in high-income countries. Common comorbidities included hypertension (50.9%), coronary heart disease (49.6%), and atrial fibrillation (24.4%). The overall use of diuretics, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEI/ARB), and β-blockers at admission was 30.1%, 27.0%, and 25.6%, respectively, which was lower than in other registries. For patients discharged alive, ACEI/ARB, β-blocker, and mineralocorticoid receptor antagonist use in patients with reduced ejection fraction was 67.5%, 70.0%, and 74.1%, respectively; device use was much lower. The median length of hospital stay was 10 (range 7–15) days, and in-hospital mortality was 4.1 ± 0.3%. Predictors of mortality included low systolic blood pressure, acute myocardial infarction, infection, right bundle branch block, and elevated total bilirubin and blood urea nitrogen level. Conclusions Several important findings in patient profile and treatment patterns among Chinese patients with HF were noted compared with published literature. These data underscore the need for regional characterization of HF for global clinical trials and for the identification of several quality improvement opportunities. Highlights The first characterization of patients admitted for heart failure in China is presented. Differences in patient characteristics and treatments were identified in China compared with other registries. A high prevalence of patients discharged from the hospital for heart failure did not receive target drug dosing. Low systolic blood pressure, acute myocardial infarction, infection, right bundle branch block, and elevated total bilirubin and blood urea nitrogen were predictors of in-hospital mortality in Chinese patients with heart failure.

    원문보기

    원문보기
    무료다운로드 유료다운로드

    회원님의 원문열람 권한에 따라 열람이 불가능 할 수 있으며 권한이 없는 경우 해당 사이트의 정책에 따라 회원가입 및 유료구매가 필요할 수 있습니다.이동하는 사이트에서의 모든 정보이용은 NDSL과 무관합니다.

    NDSL에서는 해당 원문을 복사서비스하고 있습니다. 아래의 원문복사신청 또는 장바구니담기를 통하여 원문복사서비스 이용이 가능합니다.

    이미지

    Fig. 1 이미지

논문관련 이미지